Ultragenyx Pharmaceutical, Inc. (RARE)
23.88
-0.82
(-3.32%)
USD |
NASDAQ |
Feb 09, 16:00
23.80
-0.08
(-0.34%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Accounts Payable (Quarterly) : 40.57M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 34.45M |
| Johnson & Johnson | -- |
| CorMedix, Inc. | 20.45M |
| Insmed, Inc. | 79.59M |
| Apellis Pharmaceuticals, Inc. | 38.60M |